Cargando…

Cost-Related Medication Nonadherence and Desire for Medication Cost Information Among Adults Aged 65 Years and Older in the US in 2022

IMPORTANCE: Rising prescription drug costs and increasing prices for consumer goods may increase cost-related medication nonadherence. Cost-conscious prescribing can be supported by real-time benefit tools, but patient views on real-time benefit tool use and their potential benefits and harms are la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dusetzina, Stacie B., Besaw, Robert J., Whitmore, Christine C., Mattingly, T. Joseph, Sinaiko, Anna D., Keating, Nancy L., Everson, Jordan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196872/ https://www.ncbi.nlm.nih.gov/pubmed/37200029 http://dx.doi.org/10.1001/jamanetworkopen.2023.14211

Ejemplares similares

Physician Perspectives on Implementation of Real-Time Benefit Tools: A Qualitative Study
por: Everson, Jordan, et al.
Publicado: (2022)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Prevalence and Persistence of Cost-Related Medication Nonadherence Among Medicare Beneficiaries at High Risk of Hospitalization
por: De Avila, Jorge L., et al.
Publicado: (2021)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older With Chronic Diseases
por: Lee, Shinduk, et al.
Publicado: (2018)

Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021)

Association of Electronic Prescribing of Controlled Substances With Opioid Prescribing Rates
por: Everson, Jordan, et al.
Publicado: (2020)

Medication Nonadherence in Diabetes: Longitudinal effects on costs and potential cost savings from improvement
por: Egede, Leonard E., et al.
Publicado: (2012)

Cost Reduction Behaviors and Cost-Related Medication Nonadherence in Older Adults with Atrial Fibrillation
por: Bamgbade, Benita, et al.
Publicado: (2021)

Cost-related nonadherence to prescription medications in Canada: a scoping review
por: Gupta, Shikha, et al.
Publicado: (2018)

Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US
por: Horný, Michal, et al.
Publicado: (2021)

Estimated Cost of Developing a Therapeutic Complex Medical Device in the US
por: Sertkaya, Aylin, et al.
Publicado: (2022)

Cost-Related Antihypertensive Medication Nonadherence: Action in the Time of COVID-19 and Beyond
por: Tajeu, Gabriel S, et al.
Publicado: (2020)

Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population
por: Li, Mengyao, et al.
Publicado: (2023)

Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
por: Sachs, Rachel E., et al.
Publicado: (2021)

Recent Trends in Cost-Related Medication Nonadherence Among Cancer Survivors in the United States
por: Lee, Min Jee, et al.
Publicado: (2018)

Medication Nonadherence and Risk of Violence to Others Among Patients With Schizophrenia in Western China
por: Li, Yang, et al.
Publicado: (2023)

Medication nonadherence and psychiatry
por: Chapman, Sarah C.E., et al.
Publicado: (2013)

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
por: Erath, Alexandra, et al.
Publicado: (2020)

Cost-Related Nonadherence to Medications Among Patients With Diabetes and Chronic Pain: Factors beyond finances
por: Kurlander, Jacob E., et al.
Publicado: (2009)

Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact
por: Holbrook, Anne M., et al.
Publicado: (2021)

Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018
por: Li, Meng, et al.
Publicado: (2021)

Developing an Integrated Longitudinal Dataset for Patient-Centered Outcome Measures in Cost-Related Medication Nonadherence
por: Zhang, James X., et al.
Publicado: (2023)

National Trends in Cessation Counseling, Prescription Medication Use, and Associated Costs Among US Adult Cigarette Smokers
por: Tibuakuu, Martin, et al.
Publicado: (2019)

Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit
por: Rotenstein, Lisa S., et al.
Publicado: (2018)

Identifying Conditions With High Prevalence, Cost, and Variation in Cost in US Children’s Hospitals
por: Gill, Peter J., et al.
Publicado: (2021)

The Cascade of Medical Services and Associated Longitudinal Costs Due to Nonadherent Magnetic Resonance Imaging for Low Back Pain
por: Webster, Barbara S., et al.
Publicado: (2014)

Nonadherence to Any Prescribed Medication Due to Costs Among Adults with HIV Infection — United States, 2016–2017
por: Beer, Linda, et al.
Publicado: (2019)

The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
por: Etteldorf, Andrew, et al.
Publicado: (2022)

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022)

Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US
por: Zaorsky, Nicholas G., et al.
Publicado: (2021)

Accuracy of Physician Estimates of Out-of-Pocket Costs for Medication Filling
por: Sloan, Caroline E., et al.
Publicado: (2021)

Cost-Related Medication Nonadherence (CRN) on Healthcare Utilization and Patient-Reported Outcomes: Considerations in Managing Medicare Beneficiaries on Antidepressants
por: Alnijadi, Abdulrahman A., et al.
Publicado: (2021)

Impact of Cost-Related Medication Nonadherence on Economic Burdens, Productivity Loss, and Functional Abilities: Management of Cancer Survivors in Medicare
por: Lu, Z. Kevin, et al.
Publicado: (2021)

An adapted model of cost-related medication nonadherence among older adult patients with chronic diseases: an Iranian qualitative study
por: Rezaei, Soheila, et al.
Publicado: (2023)

Prescription drug coverage satisfaction, cost-reducing behavior, and medication nonadherence among Medicare beneficiaries with type 2 diabetes
por: He, Qing, et al.
Publicado: (2021)

Evaluation of Medicare Coverage and Estimated Out-of-Pocket Costs for Generic Abiraterone Products
por: Gupta, Arjun, et al.
Publicado: (2022)

Costs of Prescription Drugs for Children and Parental Adherence to Long-Term Medications
por: Lauffenburger, Julie C., et al.
Publicado: (2023)

Citizenship status and cost‐related nonadherence in the United States, 2017–2021
por: Guadamuz, Jenny S., et al.
Publicado: (2023)

Association of Outpatient Behavioral Health Treatment With Medical and Pharmacy Costs in the First 27 Months Following a New Behavioral Health Diagnosis in the US
por: Bellon, Johanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nr7pm32fj8mtb61rhfnt8qfp8c